Open access

Antiproliferative Effect and Induction of Apoptosis by Inula viscosa L. and Retama monosperma L. Extracts in Human Cervical Cancer Cells

Written By

L. Benbacer, N. Merghoub, H. El Btaouri, S. Gmouh, M. Attaleb, H. Morjani, S. Amzazi and M. El Mzibri

Submitted: 19 July 2011 Published: 02 March 2012

DOI: 10.5772/30025

From the Edited Volume

Topics on Cervical Cancer With an Advocacy for Prevention

Edited by Rajamanickam Rajkumar

Chapter metrics overview

4,446 Chapter Downloads

View Full Metrics

1. Introduction

Worldwide cervical cancer is the second most common malignancy in women with nearly a half million new cases diagnosed and 250,000 deaths each year Almost 80% of cases occur in low-income countries, where cervical cancer is the most common cancer in women (WHO, 2009). In spite of recent advances in the development of new anticancer agents, cancer continues to be one of the major causes of death worldwide. Resistance to chemotherapeutic agents remains a principal obstacle in the successful treatment of cancer. Therefore, development and search of novel and effective anticancer agents to overcome resistance have become very important issues.

As other cancers, radiotherapy and chemotherapy are the conventional cancer treatment used nowadays and remain the routine method for the treatment of cervical cancer. These approaches present sole limits related to the cost, problems of unstable efficiency and severe side effects whose reduce the quality of life and discourage patients to observe medication protocols which then lead to the progression of cancer and associated complications. In addition, many of these treatments present limited anti-cancer activities (Mans, 2000). Therefore, development and search of novel and effective anticancer agents to overcome resistance and without severe side effects have become very important issues.

During last decades, natural products have been an important source of chemotherapeutics, more than half of effective cancer drugs can be traced to natural origins (Ma, 2009). Approximately 60% of drugs currently used for cancer treatment have been isolated from natural products (Gordaliza, 2007; Newman, 2007). Currently, medicinal plants constitute a common alternative for cancer treatment in many countries around the world (Gerson-Cwilich, 2006; Tascilar, 2006).

Many candidate compounds that are able to arrest proliferation and induce apoptosis in neoplastic cells have been discovered. These include Vinca Alkaloids; Taxus diterpenes; Camptotheca Alkaloids; and Podophyllum lignans. Currently, there are 16 new plant-derived compounds being tested in clinical trials and of these 13 are being tested in phase I or II, and 3 are in phase III. Among these compounds, flavopiridol, isolated from the Indian tree Dysoxylum binectariferum and mesoindigo, isolated from the Chinese plant Indigofera tinctoria, have been shown to exhibit anti-cancer effects with lesser toxicity than conventional drugs (Saklani A, 2008).

In Morocco, medicinal plants have always been associated with cultural behaviour and traditional knowledge. Herbal remedies are frequently used to treat a large variety of ailments and symptoms, like a fever, inflammation, and pain (Gonzalez-Tejero, 2008). However, there is little information about their anti-cancer properties.

Drug discovery from natural sources involves a multidisciplinary approach combining ethnobotanical, phytochemical and biological techniques to provide new chemical compounds for the development of new drugs against various pharmacological targets, including cancer and related complications. Cytotoxic screening models provide important preliminary data to select plant extracts with potential antineoplastic properties. The initial screenings are cell-based assays using established cell lines, in which the toxic effects of plant extracts or isolated compounds can be measured. Most of the clinically used antitumor agents possess significant cytotoxic activity in cell culture systems (Cardellina, 1999).

In the course to contribute to development of new anticancer drugs against cervical cancer, the human cervical carcinoma SiHa and HeLa cell lines, has been used as a model system in this study for screening promising plant materials from folk Moroccan medicine possessing anticancer effect. Thus, seven medicinal plants: Inula viscosa L. (Ait.), Retama monosperma L. (Boiss.), Ormenis mixta L. (Dumont.), Ormenis eriolepis Coss., Rhamnus lycioides L., Berberis hispanica Bois. and Urginea maritima L. (Baker.) were collected and evaluated for the in vitro cytotoxic effect against SiHa and HeLa cell lines. The selection was made on the basis of their reputation as folk medicines and ethnobotanic informations to treat different illnesses and diseases. The selected plants have been described to exhibit several biological activities. However, the antiproliferative and apoptotic effects of these plants against cervical cancer cells have not yet been explored. The second part of this study, the most active plants were then selected and were evaluated for their potential antiproliferative effects against SiHa and HeLa cells. Furthers assays were used to elucidate its cytotoxic mechanism.


2. Materials and methods

2.1. Plant species

Seven plant species were collected from different regions of Morocco and were identified by Dr. M. Fennane from the Scientific Institute of Rabat. Voucher specimens are kept in the herbarium of institute. Table 1 shows the ethnobotanical data of the investigated plant species, including botanical names, local names, ethnomedical uses, as well as the plant parts employed in this study.

Plants species (Family)Place of collectionPart plant collectedTraditional usepharmacological activities
Inula viscosa L. Ait
Ain atik TemaraLeavesSkin diseases, treats cutaneous abcesses, wound healing, Tuberculosis, bronchial infections (Bellakhdar, 1997)Anti-inflammatory effects (Hernandez, 2007; Máñez, 2007)
Antimicrobial activity (Maoz., 1998)
Antifungal activity (Cafarchia, 2002)
Retama monosperma
L. Bois (Fabaceae)
LeavesPurgative, vermifuge, antihelmintic, abortive and disinfectant (Benrahmoune, 2003)No information available
Berberis hispanica
Bois and Reut.
TamahditBark rootsBlood pressure, digestive, disorders, anorexia, urinary system, nephritic, liver and astrointestinal disorders, ocular affections, febrifuge, antileishmania, antitumoral (Bellakhdar, 1997)Antimicrobial activity (Ai-Rong, 2007)
Antitumor activities (Fukuda, 1999; Meenakshi, 2007)
Ormenis eriolepis Coss.
OuarzazatAerial partStomachic, anthelmintic and antidiabetic (Bellakhdar, 1997)Antibactrial activities (El Hanbali, 2004)
Antileishmania activities (El Hanbali, 2005)
Antifungic activity (Amani, 2008)
Ormenis mixta
Aerial partDrain the buttons, healing wounds (Haddad, 2003)Antimicrobial activity (Satrani, 2007)
Rhamnus lycioides ssp. Oleoides
LeavesLaxative, diuretic and hepatic affections (Hmamouchi, 2001)Hypotensive activity (Terencio, 1990)
Urginea maritima L. Baker
BulbsCardiac failures, whooping-cough, pneumonia, abortive, vipers bites, aphrodisiac, cough, bronchitis and the jaundice, diuretic and internal tumours (Bellakhdar, 1997)Cytotoxic and antimalarial activities (Sathiyamoorthy, 1999)

Table 1.

Ethnobotanical data and some reported pharmacological activities of plants species used in this study.

2.2. Plant extracts preparation

The seven Plants were dried and ground finely. 20g of each powdered plant were extracted by absolute methanol (100 ml, three times) for 72 h at room temperature. The extracts were evaporated to dryness under reduced pressure at 40 C. A total of 40 mg of obtained extract were dissolved in dimethyl sulfoxide (DMSO) to give a solution stock to 40 mg/ml and conserved at -20 C until use.

In second part of the study, the most actives plants were submitted to extraction with solvents with different polarities. Inula viscosa L. and Retama monosperma L. were extracted successively in a Soxhlet with n-hexane and methanol. The resulting extracts were then evaporated by Rotavapor to give dried extracts. The methanol concentrated extract was dissolved in distilled water and was successively extracted with dichloromethane and ethyl acetate. The solvent was evaporated to obtain the crudes extracts, and kept in the dark at +4 C until tested.

2.3. Cell lines

Human cervical cancer SiHa and HeLa cell lines were used in this study. Cells were grown as monolayers in Minimum Essential Medium (MEM) supplemented with 10% heat-inactivated fetal calf serum and 1% Penicillin-Spreptomycin mixture. Cultures were maintained at 37 C in 5% CO2. SiHa and HeLa cell lines were kindly provided by Dr. P. Coursaget, INSERM U618, University François Rabelais, Tours, France.

2.4. Cytotoxicity assay

Cytotoxicity of the plant extracts was determined using the MTT Assay as described previously (Mosmann, 1983). Cells were seeded in 96-well microplates. After 24 h of culture, the cells were treated with different concentrations ranging from 15.6 to 500 μg/ml, in quadruplicate for 48h or 72h incubation. 10μL MTT (5mg/mL) was added to each well. After 4 hours incubation, 150μL DMSO were added to dissolve purple formazan crystals, and absorbance was then determined using a spectrophotometer at 590nm. Mitomycin C and vinblastin (~ 95 % HPLC, sigma-Aldrich) were used as a positive control.

2.5. Detection of the morphological changes associated with apoptosis

SiHa and HeLa cells were cultured on glass chamber slides in 2 well plates and were treated with the IV-HE, IV-DF and Rm-DF for 24h, 48h and 72h at a concentration of 20µg/ml. After incubation, cells were washed with PBS twice and fixed with (4% paraformaldehyde and 0.1% Triton X-100) for 5 min. The cells were then washed with PBS and incubated with Hoecsht 33342 (10µg/ml) (Sigma) at 37 C for 30min. The cells were visualized through fluorescence inverted microscope (Axiovert 200M Zeiss, Germany) equipped with an LD achroplan 40X objective. The images were collected with a CCD cooled camera (Coolsnap HQ, Ropper Scientific).

2.6. Mitochondrial membrane potential (∆Ψm ) measurement

Analysis of mitochondrial membrane potential was carried out using the lipophilic cationic probe, JC-1 (Molecular Probes, Eugene, OR) whose monomer emits at 530 nm (green) after excitation at 500 nm. Depending on the mitochondrial membrane potential, JC-1 is able to form J-aggregates respectively from green to yellow-orange fluorescence emission (590 nm) as mitochondrial membrane becomes more polarized. Therefore, the I590nm/I530nm emission ratio value allows observation of mitochondrial dysfunction. SiHa and HeLa cells were treated with the extract for 24 h or 48h. JC-1 reagent (10µM) was added for 20 min at 37 C in the dark. Cells were then washed with PBS and centrifuged at 1500 rpm, 4 C for 5 min. The pellet was resuspended in 1 ml ice-cold PBS and the measurements were performed using the Spectrofluorometer (RF-5301PC, Shimadzu, Tokyo, Japan). Residual mitochondrial potential as percentage of control was expressed as follows: (R treated/R control) x 100; R = I590 nm/I530 nm.

2.7. Reactive oxygene species (ROS) production

Production of ROS (reactive oxygen species) was monitored via oxidation of the carboxydichlorofluorescein analog probe, C2938. SiHa and HeLa cells (2 x105) were seeded into a 6-well plate and treated with the appropriate concentration of the extract for 24 h. Control and treated cells were washed and stained with 10 µM C2938 (30 min, 37˚C). Fluorescence emission from the oxidized probe was quantified with a Spectrofluorophotometer (RF-5301PC, Shimadzu) (excitation: 488±1 nm; emission: 518±1 nm).

2.8. Western blot analysis

Cells were treated with 20 µg/ml of extracts for (24h, 48h and 72h), scrapped, washed with PBS and lysed in ice-cold lysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 1mM dithiothreitol, 10µg/ml Leupeptin, 10µg/ml aprotinin, 10% glycerol, 1%Brij (v/v)), placed on ice for 20 and centrifuged at 14,000g for 15 min at 4 C. The amount of protein was determined using the Bio-Rad protein quantification kit. Equal amounts of proteins (25-30µg/ml) was subjected to electrophorese on SDS-polyacrylamide gels and, transferred to a Nitrocellulose membrane by electroblotting. After blocking non-specific sites, the membrane was incubated overnight with appropriate primary antibodies: Monoclonal anti- pro-Caspase 3 (1/700), Monoclonal anti-β actin (dilution 1/5000), Monoclonal anti-BCl2 (1/700) and polyclonal anti- PARP (1/1000). Horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG were used as secondary antibodies and proteins were detected using an enhanced chemiluminescence (ECL) kit.

2.9. Gas chromatography/mass spectrometry (GC/MS) analysis

The identification of the compounds from I. viscosa hexanic fraction (IV-HE) and R. monosperma dichloromethane fraction (Rm-DF) was performed by (GC/MS) analysis using a Hewlett Packard 5890 II Gaz Chromatograph, equipped with a HP 5972 Mass selective detector and a VB5 ( 5% phenyl ; 95% methylpolisyloxane) capillary column (30 m, 0.25 mm, film thickness 0.25 µm). Injection volume was 1 µl with a splitless; the injector and detector temperatures was held constant at 250. For GC/MS detection an electron ionization system with ionization energy of 70 eV was used. Helium was used as the carrier gas with an inlet pressure of 10.48 psi, corresponding to a flow rate of 1.0 ml/min. The analytical conditions worked the following programme: oven temperature from 60 to 280 C at rate of 16 C min -1, the final temperature of 300 C was held for 10 min. Tentative identification of the compounds was based on the comparison of their relative retention time and spectral mass with those of Nist and Wiley7 library data of the GC/MS system.

2.10. Statistical analysis

Data are presented as means ± SD of at least triplicate or quadruplicate determinations of three different assays. The statistical analysis was performed by student’s-test with Microsoft excel software. Significant differences are indicated by *p < 0.05; **p < 0.01; ***p < 0.001.


3. Results and discussion

3.1. Cytotoxic effect of the medicinal plants extracts from Morocco

Crude extracts of selected plants were made by exhaustive methanol extraction. These plants extracts were tested for their potential cytotoxic effects, SiHa and HeLa cells were treated with plants extracts at different concentrations ranging from 15 to 500 μg/ml for 48h. The cells viability were determined by MTT assay. Among the 7 medicinal plant extracts, methanolic extract from Inula viscosa L. and Retama monosperma L. have been found to exhibit marked cytotoxic effect on both SiHa and HeLa cell lines. Their IC50 values were 54±12 and 99±1 µg/ml in SiHa cells and 60±8 and 112±4 µg/ml in HeLa cells, respectively. The methanolic extract of Ormenis eriolepis Coss., Ormenis mixta L. and Berberis hispanica Boiss. have lower cytotoxic effect on the cancer cell lines tested (Table 2). However, Urginea maritime L. and Rhamnus lycioides L. had insignificant or no cytotoxic effects at tested concentration with IC50 ˃500µ/ml.

Methanolic extractsIC50 ± SD (μg/ml)
Inula viscosa L.54 ± 1260 ± 8
Ormenis eriolepis Coss.94 ± 4112 ± 4
Ormenis mixta L.383 ± 26311± 14
Berberis hispanica Boiss.178 ± 5224 ± 10
Retama Monosperma L.99 ± 196 ± 4
Urginea maritime L.› 500› 500
Rhamnus lycioides L.› 500› 500
Mitomycin C6 ± 11 ± 0.30

Table 2.

Cytotoxic activity of methanolic extracts of some medicinal plants from Morocco on SiHa and HeLa cervical cancer cell lines.

Inula viscosa L. (Ait.) and Retama monosperma L. methanolic extracts showed the highest cytotoxic activity with lowest IC50 values. Previous studies have reported interesting biological activities with potential therapeutic applications of these plants. Inula viscosa L. is used in Moroccan folk medicine as antihelmintic, diuretic, anemia and as cataplasm for rheumatic pain (Hmamouchi, 2001), tuberculosis, expectorant and treatment of bronchitis (Bellakhdar, 1997). The aerial part of this plant is used as decoction in the treatment of diabetes, hypertension and renal diseases (Eddouks, 2002). This plant has been described to exhibit several biological activities such as anti-inflammatory (Hernández, 2007), antimicrobial (Maoz, 1998) and antifungal effects (Cafarchia, 2002). Retama monosperma L. is used in the traditional medicine of many countries, as a purgative, vermifuge, antihelmintic and abortive (Bellakhdar, 1997). Moreover, it has been reported that Retama Genus for a various pharmacological effects, including an hypoglycemic and diuretic (Maghrani, 2005a; Maghrani, 2005b), cytotoxic (Conforti, 2004; Hayet, 2007; López-Lázaro, 2000), antioxidant and antiviral (Edziri, 2010) and antihypertensive (Eddouks, 2007).

Cells were exposed to different concentrations of extracts for 48h. Data are expressed as IC50 values (µg/ml) and are means ± SD of three experiments. Mitomycine was used as positive control.

The cytotoxic effect of extracts from Inula viscosa L. and Retama monosperma L.

As evidenced by MTT assays, we found that hexanic (IV-HE) and dichloromethane (IV-DF) extracts from Inula viscosa were able to inhibit cell growth in dose-dependent manner after 72h of treatment, in both cell lines. The IC50 values for IV-HE on SiHa and HeLa were 9.56±1.68 and 13.17±0.79 μg/ml, respectively. However, for IV-DF, the IC50 values on SiHa and HeLa were respectively 6.54±1.46 and 22.04±3.31 μg/ml. Retama monosperma dichloromethane fraction (Rm-DF) was the most active extract, exhibiting also cytotoxic activity against both cells lines in dose-dependent manner. Values of IC50 obtained were 14± and 21±µg/ml, in SiHa and HeLa cell lines respectively (Table 3). The American National Cancer Institute assigns a significant cytotoxic effect of promising anticancer product for future bio-guided studies if it exerts an IC50 value ˂30 μg/ml (Suffnes, 1990). The obtained results indicate that IV-HE and IV-DF and Rm-DF were shown to induce significant and dose-dependent inhibitory activities against human cervical cancer cell lines SiHa and HeLa.

ExtractsIC50 (µg/ml)
Retama monosperma L. extracts
Hexane extract (Rm-HE)› 80› 80
Methanol extract (Rm-ME)› 80› 80
Dichloromethane fraction (Rm-DF)14.57±4.1521.33±7.88
Acetate ethyle fraction (Rm-AF)27.54±5.6477.47±2.25
Inula viscosa L. extracts
Hexane extract (IV-HE)9.56 ± 1.68 13.17±0.79
Methanol extract (IV-ME)52.83±3.28 › 80
Dichloromethane fraction (IV-DF)6.54±1.46 22.04±3.31
Ethyl acetate fraction (IV-AF)63.62±10.55 › 80
Vinblastin10.88±0.78 6.28±0,35

Table 3.

Cytotoxic effect of extracts and fractions of Retama monosperma L. and Inula viscosa L. extracts against SiHa and HeLa cervical cancer cells.

Cells were exposed to different concentrations of extracts for 72h. As determined by MTT assay. Data are expressed as IC50 values (µg/ml) and are means ± SD of three experiments. Vinblastin was used as a positive control.

3.2. Chemical identification of plants extracts

Analyses of the most active extracts by gas chromatography (GC) coupled with and GC-mass spectrometry (MS) revealed the presence of a sesquiterpene acid: isocostic acid (46.05%) and two sesquiterpenes lactones: tomentosin (33.27%) and inuviscolide (13.04%), as major compounds in IV-HE extract (Table 4). In the fact, Inula viscosa L. is source of a number of bioactives compounds as well as flavonoids (Hernandez, 2007) and sesquiterpene derivatives (Fontana, 2007).

ExtractsCompoundsRTArea (%)
Isocostic acid40.5646.05
Isoaromadendrene epoxide41.381.44
Phenanthrene, 7-ethenyl-1,2,3,4,4α,4β,5,6,7,8,10,10α- dodecahydro-4α,7-dimethyl-1-methylene-, [4αS-(4αα',4βα',7α',10αα')]-42.740.69
6,9,12,15-Docosatetraenoic acid, methyl ester46.820.37
Quercetin 7,3',4'-trimethoxy46.930.22
Tetracosane 54.320.77
6-Imino-8-(3',5'-dichlorolphenyl)-3,4-dihydro-2H, 6H-pyrimido[2,1-β][1,3]thiazine-7-carbonitrile57.780.39
IV-DFBenzeneacetic acid, α',4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester 18 .9110.44
Isocostic acid40.562.29
1 ,2-longidione44.545.03
10 hydroxy-1 ,4,5,8-Tetramethyl anthrone44.842.54
Chiapin B46.271.55
2,4,7 Trimethyl-5 ,6-diphenyl-1H-isoindol-1 ,3(2H)-dione47.019.12
Methyl 2,3-Dideoxy-4-O-propargyl-6-O-(tert-butyldimethylsilyl)-α-D-erythro-hex-2-enopyranoside55.927.24

Table 4.

rea (%):(%): area percentage (peak area relative to the total peak area percentage).RT : Retention time (min). Compounds present within Inula viscosa L. extracts identified by CG/MS.

However, CG/MS analysis of Rm-DF (Table 5) revealed the presence of five known quinolizidine alkaloids as well as, sparteine (10.97%), L- methyl cytisine (9.11%), 17-oxosparteine (3.49%), lupanine (0.93%) and anagyrine (39.63%). The Retama species have been reported to contain alkaloids (Abdel Halim, 1997) and flavonoids (Kassem, 2000). Fifteen quinolizidine and 3 dipiperidine alkaloids were isolated from the leaves of flowering plants of R. monosperma collected from Morocco (Touati, 1996).

Benzeneacetic acid, α,4-bis[(trimethylsilyl)oxy]-,18.914.71
trimethylsilyl ester
Hexadecanoic acid42,710.86
L methyl cytisine 44,239.11
17- oxosparteine46,673.49
Anagyrine53 ,7339.63

Table 5.

rea (%):(%): area percentage (peak area relative to the total peak area percentage).RT : Retention time (min). Compounds present within R. monosperma L. extracts identified by CG/MS.

3.3. Molecular mechanisms of apoptosis signalling pathways

Induction of apoptosis constitute an important mechanism for anticancer effects of many naturally occurring and synthetic agents. Activation of apoptotic pathways seems to be an effective strategy against tumor progression (Brown, 2005). The caspase pathway plays a pivotal role in the induction, transduction and amplification of intracellular apoptotic signals. Among the caspase family proteins, capase-3 is responsible for the proteolytic cleavage of many key proteins such as PARP, which is considered as a marker of apoptosis (Kothakota, 1997; Wang, 2005).

3.4. IV-HE, IV-DF and Rm-DF induced apoptosis in SiHa and HeLa cells

In order to determine whether plant extracts induced cell death was due to apoptosis, we analyzed chromatin condensation and nuclear fragmentation by Hoechst 33342 staining and fluorescence microscopy (Kerr, 1994). SiHa and HeLa cells were treated with IV-HE, IV-DF and Rm-DF for 24h, 48h and 72h. As shown in Figure 1, the rate of apoptotic cells was increased significantly in a time-dependant manner after treatment with IV-HE, IV-DF and Rm-DF (Figure.1).

Figure 1.

IV-HE, IV-DF and Rm-DF induce apoptosis of cervical cancer cells. SiHa (A) and HeLa (B) cells were treated IV-HE, IV-DF and Rm-DF and stained with Hoechst 33342. Condensed, fragmented nuclei and apoptotic bodies were seen in the treated cells. The stained nuclei were visualized and photographed with an inverted fluorescence microscope (Axiovert 200M Zeiss). Data represent at least two experiments (Magnification: x 400).

3.5. Expression of Pro-caspase, Bcl2 and PARP cleavage

Inula viscosa and Retama monosperma extracts were able to induce apoptosis in HeLa and SiHa cells as evidenced by western blot analysis. Activation of caspase-3 causes the cleavage of poly-(ADP-ribose)-polymerase (PARP), a hallmark of apoptosis, to produce an 85 kDa fragment during apoptosis (Tewari, 1995). After treatment of cells, a procaspase-3 cleavage and cleavage of poly (ADP-ribose) polymerase (PARP) were observed in time- and dose-dependent manner. IV-HE, IV-DF and Rm-DF caused the proteolytic cleavage of PARP with accumulation of the 85 kDa fragment in SiHa and HeLa cells (Figure 2.A; 2.B). This

Figure 2.

Expression of Pro-caspase 3, Bcl-2 and PARP proteins in HeLa and SiHa treated-cells analysed by Western blot. After treatment with 20µg/ml of IV-HE, IV-DF (A) and Rm-DF (B) during 24h and 48 h or 72h, cell lysates were prepared and the proteins were separated on SDS-polyacrylamide gel and transferred into nitrocellulose membranes. The membranes were probed with the indicated antibodies. β-actin was used as a control for protein loading. The results shown here were from two or three representative experiments.

suggests that apoptosis induced by IV-HE, IV-DF and Rm-DF could be associated with a caspase-dependent pathway.

The activation and function of caspases are regulated by various key of molecules, such as inhibitors of apoptosis protein, Bcl-2 protein family. Increased expression of the anti-apoptotic protein Bcl-2 causes resistance to chemotherapeutic drugs, while decreasing Bcl-2 expression may promote apoptotic responses to anticancer drugs (Reed J.C., 1994). Our investigations showed a significant decrease in Bcl-2 expression after 24h treatment with IV-HE, IV-DF and Rm-DF (Figure 2A, 2B).

3.6. Statut of mitochondrial membrane potential

Mitochondrial dysfunction has been shown to participate in the induction of apoptosis. Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (ΔΨm), release of apoptogenic factors and loss of oxidative phosphorylation (Zimmermann, 2001). To characterize the effect of IV-HE, IV-DF and Rm-DF on the mitochondrial apoptotic pathway, we measured the mitochondrial membrane potential (∆Ψm) in SiHa and HeLa cells after treatment for 24h. As shown in (Figure.3), IV-HE, IV-DF and Rm-DF, induced a significant decrease in mitochondrial membrane potential (ΔΨm), in both SiHa and HeLa cells.

Figure 3.

Mitochondrial membrane potential state in treated cells with IV-HE, IV-DF and Rm-DF, measured by spectrofluorometry and JC-1 probe in SiHa (A) and HeLa (B). Cells are treated with 20µg/ml of extracts for 24h as described in Materials and Methods. The results are presented as the mean ± SD of three independent experiments.

3.7. Measurement of ROS production

Mitochondria are a source of ROS during apoptosis and reduced mitochondria membrane potential leads to increased generation of ROS and apoptosis (Zamzami, 1995). We investigate whether the intracellular ROS are involved in the signal transduction pathways of apoptosis. ROS generation was measured after cells treatment with IV-HE, IV-DF and Rm-DF (20µg/ml) for 24h, using a ROS-sensitive fluorescent C2938 probe. Tested extracts showed a dose-dependent increase in the intracellular ROS production when compared to the control (Figure.4). This indicate that ROS generation induced by IV-HE, IV-DF and Rm-DF in SiHa and HeLa cells can contribute to apoptosis via the mitochondrial pathway.

Figure 4.

ROS production in treated cells with IV-HE, IV-DF and Rm-DF, using an oxydation-sensitive fluorescent C2938 probe in SiHa (A) and HeLa (B). Cells are treated with 20µg/ml of extracts for 24h as described in Materials and Methods. The results are presented as the mean ± SD of three independent experiments.

Taken together, these results show clearly that the hexanic extract of Inula viscosa and dichloromethane fractions of both Inula viscosa and Retama monosperma have cytotoxic effects against cervical cancer cell lines SiHa and Hela by inducing apoptotic process. Previous studies have showed that some plant extracts with pronounced cytotoxic in vitro had marked effects in vivo and showed promising potential to be used as an anticancer drugs. Indeed, sesquiterpene lactones, isolated from Carpesium rosulatum, have recently been largely studied for their pharmacological proprieties as anti-neoplastic agents (Ma G, 2009; Moon, 2011; Robinson, 2008; Taylor, 2008). Sesquiterpenes lactones, artemisinin, thapsigargin and parthenolide and many of their synthetic derivatives, are in advanced stage for clinical trials (Ghantous, 2010).

Phytochemicals contained in Inula viscosa L. extracts including like tomentosin and inuviscolide, as evidenced by CG/MS analysis, have been shown recently to possess an antiproliferative and apoptotic effects on human melanoma cell lines (Rozenblat, 2008).

Quinolizidine alkaloids are known to present in Retama monosperma as main active constituents. Quinolizidine alkaloids contained in the dichloromethane fraction of Retama monosperma L. extract, may act as potential in vitro cytotoxic agents against human cervical cancer cells through the induction of apoptosis. In fact, previous reports have shown that quinolizidine alkaloids have been found to elicit a range of biological activities, including antiviral (Ding, 2006), antihypoglycemic (Brukwicki, 2009) and anti-tumoral (Zhang, 2010) activities.


4. Conclusion

The hexanic extract of Inula viscosa and dichloromethane fractions of both Inula viscosa and Retama monosperma showed pronounced cytotoxic effects against cervical cancer cell lines through the inhibition of proliferation and induction of apoptosis caspase-dependent and involving a mitochondria-mediated signaling pathway. Our findings suggest that these extracts might provide compounds which could be potential sources of anticancer drug leads. Further investigation into the isolation, characterization and mechanism of cytotoxic compounds from the selected plants extracts and in vivo are necessary. Moreover it will be interesting to use some in vivo models to evaluate the anti-tumor activity of these plant extracts.


  1. 1. AbdelHalim. O. B.AbdelFattah. H.HalimA. F.MurakoshiI. 1997 Comparative chemical and biological studies of the alkaloidal content of Lygos species and varieties growing in Egypt. Acta Pharm Hung 67 241247 .
  2. 2. Ai-RongL.ZhuY.LiX. N.TianX. J. 2007 Antimicrobial activity of four species of Berberidaceae. Fitoterapia 78 379381 .
  3. 3. AmaniH.RouhiR.IdrissiHassani. L. M. 2008 Étude anatomique et screening phytochimique de trois espèces du sud marocain: Chamaecytisus mollis, Retama monosperma et Hesperolaburnum platycarpum. Détermination du potentiel antifongique des extraits aqueux. Agadir, Maroc. The 3rd International Symposium on Aromatic and Medicinal Plants (SIPAM3).The first International symposium on Bioactive Molecules (CIMB1) Oujda-Morocco 29th and 30th of May;.
  4. 4. BellakhdarJ. 1997 La pharmacopée marocaine traditionnelle. Médecine arabe ancienne et savoirs populaires. Ed. Ibis press.
  5. 5. Benrahmoune I.Z. 2003 Invitation à l’Amour des plantes- Réserve biologique de Sidi-Boughaba. Ed. Scriptra. 114 228227 .
  6. 6. BrownJ. M.AttardiL. D. 2005 Opinion: the role of apoptosis in cancer development and treatment response Nat. Rev. Cancer 5 231237 .
  7. 7. BrukwickiT.WłodarczakJ.W.W. 2009 The spatial structure of 13a-hydroxy-2-thionosparteine- a potential hypoglycemic agent- and some related compounds. Journal of Molecular Structure 928 189194 .
  8. 8. CafarchiaC.De LaurentisN.MililloM. A.LosaccoV.PucciniV. 2002 Antifungal activity of essential oils from leaves and flowers of Inula viscosa (Asteraceae) by Apulian region. Parassitologia 44 153156
  9. 9. CardellinaJ. H.FullerR. W.GambleW. R.WestergaardC.BoswellJ.MunroM. H. G.CurrensM.BoydM. P. 1999 Evolving strategies for the selection dereplication and prioritization of antitumor and HIV- inhibitory natural products extracts. In: Bohlin, L., Bruhn, J.G. (Eds), Bioassay Methods in natural product Research and Development. Kluwer Academic Publishers, Dordrecht, 2536 .
  10. 10. ConfortiF.StattiG.TundisR.LoizzoM. R.BonesiM.MenichiniF.HoughtonP. J. 2004 Antioxidant and cytotoxic activities of Retama raetam subsp. Gussonei. Phytother Res 18 585587 .
  11. 11. DingP. L.HuangH.ZhouP.D. F. 2006 (2006) Quinolizidine alkaloids with anti-HBV activity from Sophora tonkinensis. Planta Med 72 854856 .
  12. 12. EddouksM.MaghraniM.LemhadriA.OuahidiM. L.JouadH. 2002 Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol 82 97103 .
  13. 13. EddouksM.MaghraniM.LouedecL.HalouiM.MichelJ. B. 2007 Antihypertensive activity of the aqueous extract of Retama raetam Forssk. leaves in spontaneously hypertensive rats. J Herb Pharmacother 7 6577 .
  14. 14. EdziriH.MastouriM.CheraifI.AouniM. 2010 Chemical composition and antibacterial, antifungal and antioxidant activities of the flower oil of Retama raetam (Forssk.) Webb from Tunisia. Nat Prod Res 24 789796 .
  15. 15. FontanaG.La RoccaS.PassannantiS.PaternostroM. P. 2007 Sesquiterpene compounds from Inula viscosa. Nat Prod Res 21 824827 .
  16. 16. FukudaK.HibiyaY.MutohM.KoshijiM.AkaoS.FujiwaraH. 1999 Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 66 227233 .
  17. 17. Gerson-CwilichR.Serrano-OlveraA.Villalobos-PrietoA. 2006 Complementary and alternative medicine (CAM) in Mexican patients with cancer. Clinical and Transitional Oncology 8 200207 .
  18. 18. GhantousA.Gali-MuhtasibH.VuorelaH.SalibaN. A.DarwicheN. 2010 What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today 15 668678 .
  19. 19. Gonzalez-TejeroM. R.Casares-PorcelM.Sanchez-RojasC. P.Ramiro-GutierrezJ. M.Molero-MesaJ.PieroniA.GiustiM. PasqualeC.Della A.Paraskeva-HadijchambiD.HadjichambisA.HoumaniZ.El -DemerdashM.El -ZayatM.HmamouchiM.EljohrigS. 2008 Medicinal plants in the Mediterranean area: synthesis of the results of the project Rubia. J Ethnopharmacol 116 341357 .
  20. 20. GordalizaM. 2007 Natural products as leads to anticancer drugs. Clin Transl Oncol 9 767776 .
  21. 21. El HanbaliF.MelloukiF.AkssiraM.BalasquezA. 2004 Etude Comparative des Compositions Chimiques et de l’Activité Antibactérienne des Huiles Essentielles de Chamaemelum eriolepis Maire et Chamaemelum Africana J.&Four. 1er Congrès Maroco-Espagnol sur la Chimie Organique et 4ème Rencontre Andalou-Marocaine sur la Chimie des Produits Naturels 1618 sept.
  22. 22. El HanbaliF.OulmoukhtarA. S.LemraniM.AkssiraM.MelloukiF. 2005 Activité anti-leishmanienne des huiles essentielles de deux camomilles : Ormenis eriolepis et Ormenis africana. International Congress On Medicinal Plants, Errachidia March 1619 , Morocco.
  23. 23. HaddadP. S.DepotM.SettafA.ChabliA.CherrahY. 2003 Comparative study on the medicinal plants most recommended by traditional practitioners in Morocco and Canada. J. Herbs Spices Med. Plants 10 2545 .
  24. 24. HayetE.SamiaA.PatrickG.AliM. M.MahaM.LaurentG.MighriZ.MahjoubL. 2007 Antimicrobial and cytotoxic activity of Marrubium alysson and Retama raetam grown in Tunisia. Pak J Biol Sci 10 17591762 .
  25. 25. HernándezV.RecioM. C.ManezS.GinerR. M.RiosJ. L. 2007 Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism. Life Sci 80 480488 .
  26. 26. HmamouchiM. 2001 Les plantes Médicinales et aromatiques Marocaines. 2ème édition Impri Fédala (Mohammadia): 108109 .
  27. 27. KassemM.MosharrafaS. A.SalehN. A.Abdel-WahabS. M. 2000 Two new flavonoids from Retama raetam. Fitoterapia 71 649654 .
  28. 28. KerrJ. F.WinterfordC. M.HarmonB. V. 1994 Apoptosis. Its significance in cancer and cancer therapy. Cancer 73 20132026 .
  29. 29. KothakotaS.AzumaT.ReinhardC.KlippelA.TangJ.ChuK.Mc GarryT. J.KirschnerM. W.KothsK.KwiatkowskiD. J.WilliamsL. T. 1997 Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278 294298 .
  30. 30. López-LázaroM.Martin-CorderoC.CortesF.PineroJ.AyusoM. J. 2000 Cytotoxic activity of flavonoids and extracts from Retama sphaerocarpa Boissier. Z Naturforsch C 55 4043 .
  31. 31. MaG.ChongL.LiZ.CheungA. H.M. H.T. 2009 Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer Chemother Pharmacol 64 143152
  32. 32. MaX.WangZ. 2009 Anticancer drug discovery in the future: an evolutionary perspective. Drug Discovery Today 14 11371142 .
  33. 33. MaghraniM.MichelJ. B.EddouksM. 2005 Hypoglycaemic activity of Retama raetam in rats. Phytother Res 19 125128 .
  34. 34. MaghraniM.ZeggwaghN. A.HalouiM.EddouksM. 2005 Acute diuretic effect of aqueous extract of Retama raetam in normal rats. J Ethnopharmacol 99 3135 .
  35. 35. MáñezS.HernándezV.GinerR. M.RíosJ. L.RecioM. C. 2007 Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa. Fitoterapia 78 329331 .
  36. 36. MansD. R.daRocha. A. B.SchwartsmannG. 2000 anticancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anticancer compounds. Oncologist 5 185198 .
  37. 37. MaozM.NeemanI. 1998 Antimicrobial effects of aqueous plant extracts on the fungi Microsporum canis and Trichophyton rubum and on three bacterial species. Lett. Appl. Microbiol 26 6163 .
  38. 38. MeenakshiS.SrivastavaS. 2007 Antimicrobial activities of Indian Berberis species. Fitoterapia 78 574576 .
  39. 39. MoonH. I.ZeeO. 2011 Anticancer activity of sesquiterpene lactone from plant food (Carpesium rosulatum) in human cancer cell lines. Int J Food Sci Nutr 62 102105 .
  40. 40. NewmanD. J.CraggG. M. 2007 Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 70 461477 .
  41. 41. Reed J.C. 1994 Bcl-2 and the regulation of programmed cell death. J Cell Biol 124 16 .
  42. 42. RobinsonA.KumarT. V.SreedharE.NaiduV. G.KrishnaS. R.BabuK. S.SrinivasP. V.RaoJ. M. 2008 A new sesquiterpene lactone from the roots of Saussurea lappa: structure-anticancer activity study. Bioorg Med Chem Lett. 18 40154017 .
  43. 43. RozenblatS.GrossmanS.BergmanM.GottliebH.CohenY.DovratS. 2008 Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol 75 369382 .
  44. 44. SaklaniA.KuttyS. K. 2008 Plant-derived compounds in clinical trials. Drug Discov Today 13 161171 .
  45. 45. SatraniB.GhanmM.FarahA.AafiA.FougrachH.BourkhissB.BoustD.TalbiM. 2007 Composition chimique et activité antimicrobienne de l’huile essentielle de Cladanthus mixtus.. Bull. Soc. Pharm. 146 8596 .
  46. 46. SathiyamoorthyP.Lugasi-EvgiH.SchlesingerP.KedarI.GopasJ.PollackY.Golan-GoldhirshA. 1999 Screening for Cytotoxic and Antimalarial Activities in Desert Plants of the Negev and Bedouin Market Plant Products. Pharmaceutical Biology (Formerly International Journal of Pharmacognosy) 37 188195 .
  47. 47. SuffnessM.PezzutoJ. M. 1990 Assays related to cancer drug discovery. In: Hostettmann, K. (Ed). Methods in Plant Biochemistry: Assays for Bioactivity. Academic Press, London 6 71133 .
  48. 48. JongF. A.VeinweijJ.MathijssenR. H. 2006 Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist 11 732741 .
  49. 49. TaylorP. G.DupuyLoo. O. A.BonillaJ. A.MurilloR. 2008 Anticancer activities of two sesquiterpene lactones, millerenolide and thieleanin isolated from Viguiera sylvatica and Decachaeta thieleana. Fitoterapia 79 428432 .
  50. 50. TerencioM. C.SanzM. J.PayaM. 1990 A hypotensive procyanidin-glycoside from Rhamnus lycioides ssp. Lycioides. J Ethnopharmacol. 30 205214 .
  51. 51. TewariM.QuanL. T.O’RourkeK.DesnoyersS.ZengZ.BeidlerD. R.PoirierG. G.SalvesenG. S.DixitV. M. 1995 Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 801809 .
  52. 52. TouatiD.AllainP.PellecuerJ.Fkih-TetouaniS. A. 1996 Alkaloids from Retama monosperma ssp. Eumonosperma. Fitoterapia 67 4952 .
  53. 53. WangZ. B.LiuY. Q.CuiY. F. 2005 Pathways to caspase activation. Cell Biol Int 29 489496 .
  54. 54. WHO 2009 Strengthening cervical cancer prevention and control. Report of the GAVI-UNFPA-WHO meeting /RHR/10.13 (
  55. 55. ZamzamiN.MarchettiP.CastedoM.DecaudinD.MachoA.HirschT.SusinS. A.PetitP.X.MignotteB.KroemerG. 1995 Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182 367377 .
  56. 56. ZhangY.LiuH.JinJ.ZhuX.LuL.JiangH. 2010 The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependant apoptosis in human melanoma A375 cells. Anticancer Drugs 21 494501 .
  57. 57. ZimmermannK. C.GreenD. R. 2001 How cells die: apoptosis pathways. Journal of Allergy and Clinical Immunology 108 99103 .


Written By

L. Benbacer, N. Merghoub, H. El Btaouri, S. Gmouh, M. Attaleb, H. Morjani, S. Amzazi and M. El Mzibri

Submitted: 19 July 2011 Published: 02 March 2012